27914987|t|Tetrabromobisphenol A activates the hepatic interferon pathway in rats
27914987|a|Tetrabromobisphenol A (TBBPA) is a widely used flame retardant in printed circuit boards, paper, and textiles. In a two-year study, TBBPA showed evidence of uterine tumors in female Wistar-Han rats and liver and colon tumors in B6C3F1 mice. In order to gain further insight into early gene and pathway changes leading to cancer, we exposed female Wistar Han rats to TBBPA at 0, 25, 250, or 1000mg/kg (oral gavage in corn oil, 5Ã—/ week) for 13 weeks. Because at the end of the TBBPA exposure period, there were no treatment-related effects on body weights, liver or uterus lesions, and liver and uterine organ weights were within 10% of controls, only the high dose animals were analyzed. Analysis of the hepatic and uterine transcriptomes showed TBBPA -induced changes primarily in the liver (1000mg/kg), with 159 transcripts corresponding to 132 genes differentially expressed compared to controls (FDR=0.05). Pathway analysis showed activation of interferon (IFN) and metabolic networks. TBBPA induced few molecular changes in the uterus. Activation of the interferon pathway in the liver occurred after 13-weeks of TBBPA exposure, and with longer term TBBPA exposure this may lead to immunomodulatory changes that contribute to carcinogenic processes.
27914987	0	21	Tetrabromobisphenol A	T103	UMLS:C0076220
27914987	36	43	hepatic	T017	UMLS:C0023884
27914987	44	62	interferon pathway	T038	UMLS:C1512834
27914987	66	70	rats	T204	UMLS:C0034721
27914987	71	92	Tetrabromobisphenol A	T103	UMLS:C0076220
27914987	94	99	TBBPA	T103	UMLS:C0076220
27914987	118	133	flame retardant	T103	UMLS:C0016198
27914987	196	201	study	T062	UMLS:C2603343
27914987	203	208	TBBPA	T103	UMLS:C0076220
27914987	228	242	uterine tumors	T038	UMLS:C0042138
27914987	253	268	Wistar-Han rats	T204	UMLS:C2700261
27914987	273	278	liver	T038	UMLS:C0023903
27914987	283	295	colon tumors	T038	UMLS:C0009375
27914987	299	310	B6C3F1 mice	T204	UMLS:C2698297
27914987	356	360	gene	T017	UMLS:C0017337
27914987	365	372	pathway	T038	UMLS:C1704259
27914987	392	398	cancer	T038	UMLS:C0027651
27914987	418	433	Wistar Han rats	T204	UMLS:C2700261
27914987	437	442	TBBPA	T103	UMLS:C0076220
27914987	487	495	corn oil	T103	UMLS:C0010029
27914987	547	552	TBBPA	T103	UMLS:C0076220
27914987	627	632	liver	T033	UMLS:C0577053
27914987	636	650	uterus lesions	T033	UMLS:C0567079
27914987	736	743	animals	T204	UMLS:C0003062
27914987	749	757	analyzed	T062	UMLS:C0936012
27914987	759	767	Analysis	T062	UMLS:C0936012
27914987	775	782	hepatic	T017	UMLS:C0023884
27914987	787	794	uterine	T017	UMLS:C0042149
27914987	795	809	transcriptomes	T082	UMLS:C3178810
27914987	817	822	TBBPA	T103	UMLS:C0076220
27914987	857	862	liver	T017	UMLS:C0023884
27914987	885	896	transcripts	T103	UMLS:C1519595
27914987	918	923	genes	T017	UMLS:C0017337
27914987	939	948	expressed	T038	UMLS:C0017262
27914987	982	998	Pathway analysis	T170	UMLS:C0868995
27914987	1020	1030	interferon	T103	UMLS:C0021747
27914987	1032	1035	IFN	T103	UMLS:C0021747
27914987	1041	1059	metabolic networks	T038	UMLS:C1706062
27914987	1061	1066	TBBPA	T103	UMLS:C0076220
27914987	1104	1110	uterus	T017	UMLS:C0042149
27914987	1130	1148	interferon pathway	T038	UMLS:C1512834
27914987	1156	1161	liver	T017	UMLS:C0023884
27914987	1189	1194	TBBPA	T103	UMLS:C0076220
27914987	1226	1231	TBBPA	T103	UMLS:C0076220
27914987	1258	1274	immunomodulatory	T058	UMLS:C1963758
27914987	1302	1324	carcinogenic processes	T038	UMLS:C0596263